The frozen elephant trunk technique: impact of proximalization and the four-sites perfusion technique.


Journal

European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery
ISSN: 1873-734X
Titre abrégé: Eur J Cardiothorac Surg
Pays: Germany
ID NLM: 8804069

Informations de publication

Date de publication:
27 Dec 2021
Historique:
received: 01 09 2020
revised: 01 02 2021
accepted: 11 05 2021
pubmed: 12 8 2021
medline: 6 4 2022
entrez: 11 8 2021
Statut: ppublish

Résumé

To improve organ protection with the frozen elephant trunk (FET) procedure, a so-called four-sites perfusion in combination with proximalization for the distal aortic anastomosis was performed. The impact of these techniques on patient outcome is reported. Between February 2005 and April 2020, a total of 357 patients underwent the FET procedure for acute (54%) or chronic (22%) aortic dissection or aneurysmal disease (24%). The level of the distal FET anastomosis was defined according to aortic arch zones 0-3. Patients were divided into 3 groups according to the intraoperative perfusion strategy: (i) selective antegrade cerebral perfusion (SACP) alone (N = 96, 2 sites); (ii) SACP plus left subclavian artery or distal aorta (N = 84, 3 sites) and (iii) SACP plus left subclavian artery plus distal aorta (N = 177, 4 sites). Early outcome was addressed by a composite end point: occurrence of either a disabling stroke, a disabling spinal cord injury, extracorporeal circulatory support, kidney dialysis or death within 90 days. Preoperative characteristics were similar among the groups. Surgery in group C was characterized by FET proximalization in arch zone ≤2, moderate hypothermia at 28°C and shorter periods of extracorporeal circulation, SACP, hypothermic circulatory arrest and cardioplegic arrest (P < 0.001, respectively). Occurrence of the composite end point was reduced in group C (P = 0.008). The combination of FET proximalization and four-sites perfusion was a protective factor for the composite outcome in multivariable analysis (P = 0.009). The 5-year survival was improved in patients who underwent FET proximalization in zone ≤2 (hazard ratio 0.7, 95% confidence interval 0.4-1.0; P = 0.036). FET proximalization in combination with four-sites perfusion has the potential to improve patient outcomes in terms of survival and major events. 120; 161.

Identifiants

pubmed: 34378023
pii: 6347634
doi: 10.1093/ejcts/ezab295
pmc: PMC8759516
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

195-203

Informations de copyright

© The Author(s) 2021. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery.

Références

Eur J Cardiothorac Surg. 2011 Apr;39(4):519-22
pubmed: 20615719
Semin Thorac Cardiovasc Surg. 2019 Winter;31(4):679-685
pubmed: 31279912
Eur J Cardiothorac Surg. 2017 Feb 1;51(2):329-338
pubmed: 28082472
Eur J Cardiothorac Surg. 2010 Oct;38(4):507-9
pubmed: 20335043
Int J Stroke. 2009 Jun;4(3):200-5
pubmed: 19659822
Eur J Cardiothorac Surg. 2017 Aug 1;52(2):310-318
pubmed: 28575324
Eur J Cardiothorac Surg. 2019 Jan 1;55(1):133-162
pubmed: 30312382
Eur J Cardiothorac Surg. 2016 Jan;49(1):118-24
pubmed: 25669646
Eur J Cardiothorac Surg. 2009 Dec;36(6):946-55
pubmed: 19640727
Eur J Cardiothorac Surg. 2015 May;47(5):759-69
pubmed: 25769463
J Thorac Cardiovasc Surg. 2020 Apr;159(4):1201-1211
pubmed: 31208809
J Thorac Cardiovasc Surg. 2020 Jul;160(1):20-33.e4
pubmed: 31757456
J Thorac Cardiovasc Surg. 2020 Jul;160(1):37-43
pubmed: 31543306
Ann Cardiothorac Surg. 2013 Sep;2(5):612-20
pubmed: 24109569
Eur J Cardiothorac Surg. 2015 May;47(5):917-23
pubmed: 25035412
Eur J Cardiothorac Surg. 2018 Aug 1;54(2):375-381
pubmed: 29471419
J Thorac Cardiovasc Surg. 2019 Oct 4;:
pubmed: 32169371
Ann Thorac Surg. 2019 Nov;108(5):1345-1353
pubmed: 31082360
Eur J Cardiothorac Surg. 2013 Dec;44(6):1076-82; discussion 1083
pubmed: 23677901
Eur J Cardiothorac Surg. 2019 Oct 1;56(4):738-745
pubmed: 30957865
Circulation. 2017 Jun 6;135(23):2299-2307
pubmed: 28584030
J Cardiovasc Surg (Torino). 2018 Aug;59(4):540-546
pubmed: 29806768
J Thorac Cardiovasc Surg. 2015 Feb;149(2 Suppl):S65-73
pubmed: 25439767
Clin Orthop Relat Res. 2017 May;475(5):1499-1504
pubmed: 27815685
Ann Thorac Surg. 2011 Nov;92(5):1663-70; discussion 1670
pubmed: 22051263
Eur J Cardiothorac Surg. 2015 Apr;47(4):616-20
pubmed: 24944331
Minim Invasive Ther Allied Technol. 2015;24(5):311-6
pubmed: 26358834
Eur J Cardiothorac Surg. 2016 Jan;49(1):111-7
pubmed: 25715431
J Thorac Cardiovasc Surg. 2019 Mar;157(3):835-849
pubmed: 30635189
Eur J Cardiothorac Surg. 2016 Feb;49(2):660-6
pubmed: 25890937

Auteurs

Konstantinos Tsagakis (K)

Department of Thoracic and Cardiovascular Surgery, West German Heart and Vascular Center Essen, University Hospital Essen, Essen, Germany.

Anja Osswald (A)

Department of Thoracic and Cardiovascular Surgery, West German Heart and Vascular Center Essen, University Hospital Essen, Essen, Germany.

Alexander Weymann (A)

Department of Thoracic and Cardiovascular Surgery, West German Heart and Vascular Center Essen, University Hospital Essen, Essen, Germany.

Aydin Demircioglu (A)

Department of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.

Bastian Schmack (B)

Department of Thoracic and Cardiovascular Surgery, West German Heart and Vascular Center Essen, University Hospital Essen, Essen, Germany.

Daniel Wendt (D)

Department of Thoracic and Cardiovascular Surgery, West German Heart and Vascular Center Essen, University Hospital Essen, Essen, Germany.

Heinz Jakob (H)

Department of Thoracic and Cardiovascular Surgery, West German Heart and Vascular Center Essen, University Hospital Essen, Essen, Germany.

Arjang Ruhparwar (A)

Department of Thoracic and Cardiovascular Surgery, West German Heart and Vascular Center Essen, University Hospital Essen, Essen, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH